comparemela.com

Latest Breaking News On - Defendants prevailed - Page 1 : comparemela.com

Mallinckrodt plc v Airgas Therapeutics LLC - INOmax® (Nitric Oxide) | Robins Kaplan LLP

Case Name: Mallinckrodt plc v. Airgas Therapeutics LLC, Civ No. 22-1648-RGA, 2024 WL 1251260 (D. Del. Mar. 22, 2024) (Andrews, J.) - Drug Product and Patent(s)-in-Suit: INOmax® (nitric.

In re Entresto (Sacubitril/Valsartan) Patent Litigation - Entresto® (Sacubitril/Valsartan) | Robins Kaplan LLP

Case Name: In re Entresto (Sacubitril/Valsartan) Patent Litigation, C.A. Nos. 19-1979, 19-2021, 19-2053, 2023 WL 4405464 (D. Del. July 7, 2023) (Andrews, J.) - Drug Product and.

Purdue Pharma L P v Accord Healthcare Inc , - OxyContin® (Oxycodone HCl) | Robins Kaplan LLP

Case Name: Purdue Pharma L.P. v. Accord Healthcare Inc., C.A. No. 22-913-WCB, 2023 WL 5835811 (D. Del. Sept. 8, 2023) (Bryson, J.) - Drug Product and Patent(s)-in-Suit: OxyContin®.

Allergan USA, Inc v MSN Labs Private Ltd - Viberzi® (Eluxadoline) | Robins Kaplan LLP

Case Name: Allergan USA, Inc. v. MSN Labs. Private Ltd., C.A. Nos. 19-1727-RGA, 20-1479-RGA, 2023 WL 6295496 (D. Del. Sept. 27, 2023) (Andrews, J.) Drug Product and Patent(s)-in-Suit:.

Astellas Pharma Inc v Sandoz Inc Myrbetriq® (Mirabegron) | Robins Kaplan LLP

Case Name: Astellas Pharma Inc. v. Sandoz Inc., Civ. No. 20-1589, 2023 WL 3934386 (D. Del. June 9, 2023) (Bataillon, J.) Drug Product and Patent(s)-in-Suit: Myrbetriq® (mirabegron);.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.